Immunodiagnostic Capabilities of Anti–Free Immunoglobulin Light Chain Monoclonal Antibodies
Open Access
- 1 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 130 (5) , 702-711
- https://doi.org/10.1309/ajcpns6k1cyjpdba
Abstract
Overproduction of plasma cell–derived monoclonal free κ or λ immunoglobulin light chains (FLCs) is a hallmark of multiple myeloma, AL amyloidosis, andKeywords
This publication has 35 references indexed in Scilit:
- The evolving use of serum free light chain assays in haematologyBritish Journal of Haematology, 2008
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myelomaBlood, 2008
- High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosisBlood, 2007
- Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosisInternal Medicine Journal, 2007
- Serum free light chains for monitoring multiple myeloma.British Journal of Haematology, 2005
- A molecular basis for nonsecretory myelomaBlood, 2004
- Serum free light chains for monitoring multiple myelomaBritish Journal of Haematology, 2004
- Bence Jones Proteins and Light Chains of Immunoglobulins XIV.Scandinavian Journal of Immunology, 1976
- A Hidden Antigenic Site Localized to the Constant Region of Light Chains of ImmunoglobulinsScience, 1973
- Bence Jones proteins and light chains of immunoglobulins—III Inv antigenicity: A genetic expression with serologic dependency on the intact kappa light chain moleculeImmunochemistry, 1970